Incidence of acute-onset endophthalmitis after separate bilateral cataract surgeries less than 5 days apart.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
25 Jan 2019
Historique:
received: 09 10 2018
accepted: 03 01 2019
entrez: 27 1 2019
pubmed: 27 1 2019
medline: 12 2 2019
Statut: epublish

Résumé

To assess the incidence of acute-onset endophthalmitis after separate bilateral cataract surgeries less than 5 days apart (SBCS5). The medical records of all patients who underwent SBCS5 at a single medical center between October 10, 2012 and July 31, 2017 were retrospectively reviewed. The medical records for treatment of 5374 eyes of 2687 patients were examined. The mean interval between the first and second surgeries was 3 days. No case of bilateral simultaneous endophthalmitis was observed. Unilateral endophthalmitis developed in five eyes of five patients. Thus, the incidence of endophthalmitis after SBCS5 was 0.093%. All cases of endophthalmitis occurred in the first operated eye. SBCS5 was 15% less expensive than unilateral cataract surgery. The incidence of endophthalmitis after SBCS5 was acceptably low with topical but not intracamaral antibiotic prophylaxis. SBCS5 was also less expensive than unilateral cataract surgery.

Identifiants

pubmed: 30683069
doi: 10.1186/s12886-019-1028-y
pii: 10.1186/s12886-019-1028-y
pmc: PMC6347771
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : high level introduction of talent research start-up fund
ID : HLITRSF2017

Références

Curr Opin Ophthalmol. 1997 Feb;8(1):18-21
pubmed: 10168267
Eye (Lond). 1998;12 ( Pt 6):983-9
pubmed: 10326001
J Cataract Refract Surg. 2003 Jul;29(7):1281-91
pubmed: 12900233
J Cataract Refract Surg. 2004 Jun;30(6):1335-41
pubmed: 15177613
Arch Ophthalmol. 2005 May;123(5):613-20
pubmed: 15883279
Am J Ophthalmol. 2005 Jun;139(6):983-7
pubmed: 15953426
Ophthalmology. 2005 Aug;112(8):1388-94
pubmed: 15953637
J Cataract Refract Surg. 2005 Jun;31(6):1261-2
pubmed: 16039514
Ophthalmology. 2007 Apr;114(4):686-91
pubmed: 17184840
Ophthalmology. 2007 May;114(5):866-70
pubmed: 17324467
J Cataract Refract Surg. 2007 Jun;33(6):978-88
pubmed: 17531690
Indian J Ophthalmol. 2007 Sep-Oct;55(5):374-5
pubmed: 17699948
Eye (Lond). 2009 Jan;23(1):89-95
pubmed: 17917685
Ophthalmology. 2008 Mar;115(3):473-6
pubmed: 18067969
J Cataract Refract Surg. 2008 Jun;34(6):1036-7
pubmed: 18499016
J Cataract Refract Surg. 2009 Apr;35(4):629-36
pubmed: 19304082
Am J Ophthalmol. 2010 Sep;150(3):392-398.e2
pubmed: 20619391
Arq Bras Oftalmol. 2010 Nov-Dec;73(6):505-7
pubmed: 21271024
J Cataract Refract Surg. 2011 Jun;37(6):1003-8
pubmed: 21596243
J Cataract Refract Surg. 2011 Dec;37(12):2105-14
pubmed: 22108106
Br J Ophthalmol. 2013 Oct;97(10):1312-7
pubmed: 23884695
BMC Ophthalmol. 2013 Nov 15;13:71
pubmed: 24238071
J Cataract Refract Surg. 2015 Nov;41(11):2410-6
pubmed: 26703490
Ophthalmology. 1978 Apr;85(4):320-6
pubmed: 351505
Arch Ophthalmol. 1997 Sep;115(9):1142-50
pubmed: 9298055
Lancet. 1998 Sep 19;352(9132):925-9
pubmed: 9752814

Auteurs

Ying Chen (Y)

Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, 400016, China.

Yu Zhang (Y)

Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, 400016, China.

Xiaodan Li (X)

Department of Ophthalmology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, 400021, China.

Hong Yan (H)

Department of Ophthalmology, Xi'an No. 4 Hospital, Shaanxi Eye Hospital, Affiliated Guangren Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China. yhongb@fmmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH